Stock data
Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS) reported revenue of US$13.86M and net income of -US$79.62M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$13.86M | — | -US$84.42M | -US$79.62M | — |
| 2024 | US$16.15M | — | -US$89.46M | -US$77.33M | — |
| 2023 | — | — | -US$82.20M | -US$73.79M | — |
| 2022 | — | — | -US$123.48M | -US$120.72M | — |
| 2021 | — | — | -US$69.72M | -US$75.97M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$25.35M | — |
| 2026-03-31 | — | -US$23.27M | — |
| 2025-12-31 | — | -US$18.11M | — |
| 2025-09-30 | — | -US$22.00M | — |
| 2025-06-30 | US$2.82M | -US$18.35M | — |
| 2025-03-31 | — | -US$21.16M | — |
| 2024-12-31 | — | -US$35.57M | — |
| 2024-09-30 | — | -US$21.20M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.